Policy Perspective
COGR, AAMC, AAU, and APLU Submit Joint Comments to NIH on Publication Cost Limits
The Association of American Medical Colleges, Association of American Universities, Association of Public and Land-grant Universities, and COGR submitted joint feedback to the NIH opposing proposed limitations on allowable publishing costs for NIH-funded research, arguing that such limits could impede effective dissemination, create inequities among institutions, and hinder early-career researcher
F&A Cost Reimbursement Materials
COGR provides this compilation of resources, many developed by COGR, explaining Facilities and Administrative (F&A/Indirect) costs, the importance of these costs to performing research, and the necessity of their reimbursement.
Updated: Costing Points to Consider for Terminations and Suspensions (V.2)
Communications from federal agencies about terminations and suspensions are inconsistent with each other and often with sponsor policies and Uniform Guidance. This section provides a review of the relevant sections of Uniform Guidance and a list of items for institutions to consider when following sponsor policies and instructions and determining best practices.
Points to Consider for Reimbursement of Expenses Under Active Grants (V.2): Framework for Navigating the 2025 Administration Transition
Changes to federal payment systems, processes, and requirements implementing Executive Order 14222 — Implementing the President's "Department of Government Efficiency" Cost Efficiency, issued February 26, 2025, have significantly incre
COGR Advocates for Full Reinstatement of NIH Grants in Joint Association Letter to Director, Dr. Bhattacharya
The letter, signed by leading higher education associations representing the majority of U.S. biomedical research institutions, urges NIH Director Dr. Jay Bhattacharya to reinstate all NIH grants terminated under directives recently found unlawful by a federal court. While some grants are being reinstated due to court orders, the associations highlight that many others, terminated under the same d
Fact Sheet: Defend the Spend
Executive Order 14222, intended to enhance efficiency and transparency and reduce costs in federally funded research, has instead imposed significant new administrative burdens and redundancies, notably through the “Defend the Spend” initiative. These new requirements force recipients to repeatedly justify pre-approved expenses, leading to payment delays, increased costs, and wasted effort, while
COGR Submits Comments in Response to DHHS RFI: Ensuring Lawful Regulation and Unleashing Innovation to Make America Healthy Again
COGR, representing over 230 U.S. research universities and affiliated institutions, submitted detailed feedback to the Department of Health and Human Services (DHHS) on streamlining federal research regulations to reduce administrative burden, enhance regulatory consistency, and foster innovation. COGR's letter highlights the need to eliminate duplicative or inconsistent requirements across federa
COGR Submits Letter to EPA on NPRM Regarding Methylene Chloride; Regulation Under the Toxic Substances Control Act; Compliance Date Extensions
COGR, representing over 230 U.S. research institutions, submitted comments to the EPA regarding compliance date extensions for regulations on methylene chloride under TSCA. While supporting the 18-month extension, COGR questions the legal foundation for the underlying regulations, noting that the executive orders justifying them have since been revoked, and highlights that existing OSHA standards
Exploring University-Industry Collaborations at a Pivotal Moment: A Historical Insight and Potential Future Directions: June 2025 COGR Meeting
This document discusses the evolving landscape of university-industry collaborations, emphasizing the need for modernization and increased impact in light of challenges such as declining U.S. R&D leadership, funding gaps, and workforce needs. It highlights initiatives by UIDP and Georgia Tech, including efforts to streamline cross-sector partnerships, manage intellectual property, and address
